Innoviva, Inc. (INVA) Financials

INVA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.2 billion 568.6 million
2023-09-30 1.2 billion 560.6 million
2023-06-30 1.1 billion 563.2 million
2023-03-31 1.1 billion 568.3 million

INVA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 33.1 million 1.3 million
2023-09-30 43.7 million 1.4 million
2023-06-30 38.2 million 1.5 million
2023-03-31 25.7 million 1.6 million

INVA Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 61.5 million
2023-09-30 82.0 million
2023-06-30 1.3 million
2023-03-31 34.9 million

INVA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 193.5 million - 2.8 million
2023-09-30 180.0 million - 3.2 million
2023-06-30 173.0 million - 3.1 million
2023-03-31 144.0 million 444.7 million 3.4 million

INVA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 85.0 million
2023-09-30 86.2 million
2023-06-30 65.5 million
2023-03-31 89.8 million

INVA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 151000 2.4 million 26.3 million -
2023-09-30 227000 4.0 million 28.6 million -
2023-06-30 - 15.0 million 23.5 million -
2023-03-31 33000 12.6 million 19.7 million -

INVA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 89.3 million 23.1 million
2023-09-30 67.3 million 10.2 million
2023-06-30 81.0 million 9.0 million
2023-03-31 76.4 million 10.3 million

INVA

Price: $15.26

52 week price:
11.24
16.86

Earnings Per Share: 2.20 USD

P/E Ratio: 20.80

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 549332

Ebitda: 66.9 million

Market Capitalization: 925.0 million

Average Dividend Frequency: 3

Links: